Delays in receiving COVID antiviral treatments delayed caused measurable poor outcomes--study

Delays in COVID antiviral receipt raised risk of poor outcomes after ED visits by 18%, data suggest Global Virus Network scientists highlight the need for robust surveillance, enhanced biosecurity, and readiness for potential human-to-human viral transmission. CIDRAP

Longer intervals from COVID-19 symptom onset to receipt of an antiviral drug at 16 Spanish emergency departments (EDs) were linked to worse clinical outcomes in patients at high risk for disease progression, according to a study published in Internal and Emergency Medicine.

...